Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Tacrolimus

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 70,746Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    STRATA Skin Validated for XTRAC + Topical Psoriasis Treatment
    STRATA Skin Validated for XTRAC + Topical Psoriasis Treatment

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158574/23161/en/STRATA-Skin-Sciences-Receives-Continued-Validation-for-its-Personalized-Approach-with-New-Published-Study-Highlighting-XTRAC-Excimer-Laser-Treatment-Combined-with-a-Topical-Drug-in.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Lipella Pharma Reports Successful Phase 2a Results for LP-10
    Lipella Pharma Reports Successful Phase 2a Results for LP-10

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152357/0/en/Lipella-Pharmaceuticals-Announces-Positive-Final-Results-from-Phase-2a-Study-of-LP-10-in-Oral-Lichen-Planus.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    Veloxis Pharmaceuticals Presenting at 2025 Transplant Congress
    Veloxis Pharmaceuticals Presenting at 2025 Transplant Congress

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-to-present-at-2025-world-transplant-congress-302516650.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    Lipella Pharmaceuticals Finishes Phase 2a Trial of LP-310
    Lipella Pharmaceuticals Finishes Phase 2a Trial of LP-310

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057377/0/en/Lipella-Pharmaceuticals-Completes-Enrollment-in-Phase-2a-Trial-of-LP-310-for-Oral-Lichen-Planus.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share
    Nexus Pharma Receives FDA Approval for Tacrolimus Injection
    Nexus Pharma Receives FDA Approval for Tacrolimus Injection

    13 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250213151146/en

    BUSINESSWIRE
    13 Feb 2025
    Share Share
    Enforcement Report - Week of February 5, 2025
    Enforcement Report - Week of February 5, 2025

    05 Feb 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-5-2025-48670.pdf

    FDA
    05 Feb 2025
    Share Share